Panacea Biotec (PNCA.BO: Quote, Profile, Research) said on Wednesday it has signed an advance market agreement with the Government of India to manufacture Pandyflu, the firm's swine flu vaccine. The company , which has set up a manufacturing unit in Punjab for the vaccine, will have an annual capacity of 45 million doses, it said in a statement.
Panacea Biotec signs swine flu vaccine pact for India
Previous post: ‘Swine flu jab paralysed me’
Next post: Extreme Flu cases may be helped by different therapy regime